ES517540A0 - Derivados salicilicos de n-acetilcisteina. - Google Patents

Derivados salicilicos de n-acetilcisteina.

Info

Publication number
ES517540A0
ES517540A0 ES517540A ES517540A ES517540A0 ES 517540 A0 ES517540 A0 ES 517540A0 ES 517540 A ES517540 A ES 517540A ES 517540 A ES517540 A ES 517540A ES 517540 A0 ES517540 A0 ES 517540A0
Authority
ES
Spain
Prior art keywords
acetylcysteine
acid
acetilcisteina
reaction
salicylic derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES517540A
Other languages
English (en)
Spanish (es)
Other versions
ES8402258A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Isnardi Pietro & C SpA
Original Assignee
Isnardi Pietro & C SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isnardi Pietro & C SpA filed Critical Isnardi Pietro & C SpA
Publication of ES8402258A1 publication Critical patent/ES8402258A1/es
Publication of ES517540A0 publication Critical patent/ES517540A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
ES517540A 1981-11-20 1982-11-19 Derivados salicilicos de n-acetilcisteina. Granted ES517540A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT25198/81A IT1194117B (it) 1981-11-20 1981-11-20 Derivati salicilici di n-acetilcisteina

Publications (2)

Publication Number Publication Date
ES8402258A1 ES8402258A1 (es) 1984-01-16
ES517540A0 true ES517540A0 (es) 1984-01-16

Family

ID=11215991

Family Applications (1)

Application Number Title Priority Date Filing Date
ES517540A Granted ES517540A0 (es) 1981-11-20 1982-11-19 Derivados salicilicos de n-acetilcisteina.

Country Status (9)

Country Link
US (1) US4567163A (OSRAM)
EP (1) EP0080229B1 (OSRAM)
JP (1) JPS58146560A (OSRAM)
KR (1) KR890000618B1 (OSRAM)
AT (1) ATE12102T1 (OSRAM)
CA (1) CA1202618A (OSRAM)
DE (1) DE3262569D1 (OSRAM)
ES (1) ES517540A0 (OSRAM)
IT (1) IT1194117B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
IT1206515B (it) * 1983-08-09 1989-04-27 Guidotti & C Spa Labor N-acetilcisteina ederivati 2',4's-carbossimetilcisteina ad-difluoro-4-idrossi-(1,1'-bifenil)attivita' antinfiammatoria, 3-carbossilici della mucolitica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT1194474B (it) * 1983-11-23 1988-09-22 Magis Farmaceutici Derivati della cisteina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
JPH11501611A (ja) * 1993-06-18 1999-02-09 アークチュラス、ファーマシューティカル、コーポレーション 過角化及びプロテアーゼによって媒介される疾患の治療のための方法
WO1995034303A1 (en) * 1994-06-13 1995-12-21 Arcturus Pharmaceutical Corporation Method for the treatment, prevention or minimization of hair loss
GB2320431B (en) * 1996-12-20 2000-08-30 Johnson & Johnson Medical Compositions for the treatment of chronic wounds
CN102088965B (zh) * 2008-05-13 2013-05-08 根梅迪卡治疗公司 水杨酸盐(酯)缀合物在制备用于治疗代谢性病症的药物中的应用
EP2408443A1 (en) 2009-03-16 2012-01-25 Genmedica Therapeutics SL Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
EP2408441A1 (en) * 2009-03-16 2012-01-25 Genmedica Therapeutics SL Combination therapies for treating metabolic disorders
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
MX343409B (es) 2011-09-16 2016-11-04 Genmedica Therapeutics S L Combinaciones farmaceuticas que incluyen conjugados antiinflamatorios y antioxidantes utiles para tratar trastornos metabolicos.
WO2013037984A1 (en) 2011-09-16 2013-03-21 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
PT3066089T (pt) 2013-11-08 2020-01-29 Promentis Pharm Inc Derivados n-acetil-l-cisteína substituídos e compostos relacionados

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4619M (OSRAM) * 1965-02-01 1966-11-28
US4268456A (en) * 1979-09-24 1981-05-19 Ppg Industries, Inc. Process for preparing chlorothiolformates

Also Published As

Publication number Publication date
KR890000618B1 (ko) 1989-03-22
KR840002350A (ko) 1984-06-25
IT8125198A0 (it) 1981-11-20
EP0080229A1 (en) 1983-06-01
JPH059424B2 (OSRAM) 1993-02-04
ES8402258A1 (es) 1984-01-16
CA1202618A (en) 1986-04-01
ATE12102T1 (de) 1985-03-15
DE3262569D1 (en) 1985-04-18
US4567163A (en) 1986-01-28
EP0080229B1 (en) 1985-03-13
IT1194117B (it) 1988-09-14
JPS58146560A (ja) 1983-09-01

Similar Documents

Publication Publication Date Title
ES517540A0 (es) Derivados salicilicos de n-acetilcisteina.
FI942049A0 (fi) Bentsofuranyyli- ja tiofenyylialkaanikarboksyylihappojohdannaisia
SE8005890L (sv) Salter av (+)-katekin, deras framstellning och anvendning, och kompositioner innehallande dessa salter
NO20002440L (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
ES2126355T3 (es) Procedimiento para la preparacion de creatina o monohidrato de creatina.
MX9200396A (es) Derivados de benciloxifenilo, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES8800254A1 (es) Procedimiento para la obtencion de nuevos derivados de la pristinamicina iib.
SE8206984D0 (sv) Terapeutiskt medel
SE8005714L (sv) Acetoximetyl-penamforeningar anvendbara som beta-laktamasinnibitorer
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
DK164176A (da) Carboxylsyreamider, fremgangsmade til deres fremstilling samt deres anvendelse som legemidler
DE3785104D1 (de) Pharmazeutisch nuetzliche thiazolidin-4-karbonsaeure-derivate.
ATE35811T1 (de) Derivat der acetylsalicylsaeure, seine herstellung und dieses enthaltende pharmazeutische kompositionen.
JPS5340779A (en) Optically active tolpertisone, their preparation and pharmaceuticals containting the same
ES534958A0 (es) Procedimiento de preparar derivados cisteinicos
DK599885D0 (da) Trienamidforbindelser og farmaceutisk acceptable salte heraf med antiinflammatorisk og analgetisk virkning samt farmaceutisk komposition indeholdende disse
JPS52128293A (en) Preparation of 7-aminocephalosporanic acid and its derivatives
ES8203329A1 (es) Un procedimiento para la produccion de halogenuros de alco- xi-acilcarnitina
GB1240638A (en) Racemisation of alanine derivatives
KR900701838A (ko) 어류 crf
EP0019000A4 (en) OSTEOPLASTIC PROMOTOR.
ES8800144A1 (es) Procedimiento de obtencion de un tioester de la n-acetilcisteina y de sus sales de interes terapeutico
FR2044356A5 (en) 2-phenyl propionyl salicylic acid and salts - analgesics and antipyretics
DK550177A (da) Basisk alkylerede dithiosalicylsyreamider fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
FR2470111B1 (fr) Derives de la decaprenylamine, leurs sels acides d'addition et composition pharmaceutique utilisant ces produits